Ly6Chi inflammatory monocytes promote susceptibility to Leishmania donovani infection
- The Ohio State University Medical Center, Columbus, OH (United States). Dept. of Pathology; DOE/OSTI
- The Ohio State University Medical Center, Columbus, OH (United States). Dept. of Pathology
- The Ohio State University, Columbus, OH, (United States). Dept. of Environmental Health Sciences, College of Public Health
- The Ohio State University, Columbus, OH (United States). Div. of Pediatric Dentistry, College of Dentistry
- The Ohio State University Medical Center, Columbus, OH (United States). Dept. of Pathology; Baskent University, Ankara, Turkey. Dept. of Medical Microbiology, Faculty of Medicine
- U.S. Food and Drug Administration (FDA), Silver Spring, Maryland (United States). Div. of Emerging and Transfusion Transmitted Disease, Center for Biologics Evaluation and Research
- The Ohio State University Medical Center, Columbus, OH (United States). Dept. of Pathology; The Ohio State University, Columbus, OH, (United States). Dept. of Microbiology, Wexner Medical Center
Ly6Chi inflammatory monocytes (iMO) are critical for host defense against toxoplasmosis and malaria but their role in leishmaniasis is unclear. In this study, we report a detrimental role of Ly6Chi iMOs in visceral leishmaniasis (VL) caused by Leishmania donovani. We demonstrate that Ly6Chi iMOs are continuously recruited into the spleen and liver during L. donovani infection and they are preferential targets for the parasite. Using microarray-based gene expression profiling, we show that Ly6Chi iMOs isolated from the infected liver and spleen have distinct phenotypic and activation profiles. Furthermore, we demonstrate that blocking the recruitment of Ly6Chi iMOs into the liver and spleen during L. donovani infection using a CCR2 antagonist reduces the frequency of the pathogenic IFN-γ/IL10 dual producer CD4+ T cells in the spleen and leads to a significant reduction in parasite loads in the liver and spleen. Using STAT1-/- mice we show that STAT1 is critical for mediating the recruitment of Ly6Chi iMOs into organs during L. donovani infection, and adaptive transfer of wild type Ly6Chi iMOs into STAT1-/- recipients renders them susceptible to disease. Our findings reveal an unexpected pathogenic role for Ly6Chi iMOs in promoting parasite survival in VL and open the possibility of targeting this population for host-directed therapy during VL.
- Research Organization:
- Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC); U.S. Food and Drug Administration (FDA); U.S. Environmental Protection Agency (EPA)
- Grant/Contract Number:
- SC0014669
- OSTI ID:
- 1624360
- Journal Information:
- Scientific Reports, Journal Name: Scientific Reports Journal Issue: 1 Vol. 7; ISSN 2045-2322
- Publisher:
- Nature Publishing GroupCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
H-11-linked gene has a parallel effect on Leishmania major and L. donovani infections in mice
The Preclinical Validation of 405 nm Light Parasiticidal Efficacy on Leishmania donovani in Ex Vivo Platelets in a Rag2-/- Mouse Model